Mitchell Mcleod Pugh & Williams Inc. Acquires 66 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Mitchell Mcleod Pugh & Williams Inc. grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.0% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm owned 6,373 shares of the healthcare conglomerate’s stock after buying an additional 66 shares during the period. UnitedHealth Group accounts for 0.7% of Mitchell Mcleod Pugh & Williams Inc.’s portfolio, making the stock its 28th biggest position. Mitchell Mcleod Pugh & Williams Inc.’s holdings in UnitedHealth Group were worth $3,338,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. Marshall & Sterling Wealth Advisors Inc. purchased a new stake in UnitedHealth Group in the fourth quarter worth $26,000. Hurley Capital LLC bought a new stake in UnitedHealth Group in the fourth quarter worth $28,000. Aster Capital Management DIFC Ltd purchased a new stake in shares of UnitedHealth Group in the fourth quarter worth $30,000. IAG Wealth Partners LLC purchased a new stake in shares of UnitedHealth Group in the first quarter worth $42,000. Finally, Kapitalo Investimentos Ltda purchased a new stake in shares of UnitedHealth Group in the fourth quarter worth $41,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Up 1.4%

UNH stock opened at $303.81 on Monday. UnitedHealth Group Incorporated has a twelve month low of $248.88 and a twelve month high of $630.73. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.71. The stock has a market cap of $275.60 billion, a P/E ratio of 12.72, a PEG ratio of 1.46 and a beta of 0.45. The business’s 50-day moving average price is $314.52 and its 200-day moving average price is $439.94.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. The business had revenue of $109.58 billion during the quarter, compared to analysts’ expectations of $111.56 billion. During the same period in the prior year, the firm posted $6.91 earnings per share. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were issued a $2.21 dividend. The ex-dividend date was Monday, June 16th. This is a boost from UnitedHealth Group’s previous quarterly dividend of $2.10. This represents a $8.84 dividend on an annualized basis and a yield of 2.91%. UnitedHealth Group’s payout ratio is currently 37.02%.

Insider Buying and Selling

In related news, CEO Patrick Hugh Conway sold 589 shares of the business’s stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the transaction, the chief executive officer directly owned 10,398 shares of the company’s stock, valued at approximately $3,171,390. The trade was a 5.36% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Kristen Gil acquired 3,700 shares of UnitedHealth Group stock in a transaction on Thursday, May 15th. The stock was purchased at an average cost of $271.17 per share, for a total transaction of $1,003,329.00. Following the purchase, the director owned 3,818 shares in the company, valued at approximately $1,035,327.06. The trade was a 3,135.59% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders bought 109,408 shares of company stock worth $31,607,768 in the last quarter. 0.28% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on the company. Raymond James Financial cut UnitedHealth Group from a “strong-buy” rating to a “market perform” rating in a research note on Wednesday, May 14th. JPMorgan Chase & Co. increased their target price on UnitedHealth Group from $405.00 to $418.00 and gave the stock an “overweight” rating in a research note on Friday, June 20th. TD Securities reaffirmed a “hold” rating and set a $308.00 price objective (down from $520.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. Barclays dropped their price objective on UnitedHealth Group from $350.00 to $337.00 and set an “overweight” rating on the stock in a research report on Wednesday, July 9th. Finally, Royal Bank Of Canada dropped their price objective on UnitedHealth Group from $525.00 to $355.00 and set an “outperform” rating on the stock in a research report on Friday, May 16th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $415.00.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.